The compony claims they submitted the application many days ago... FINRA is not several months behind and there is no backlog. Where does that even come from??
By the way... FINRA approves stock splits for share selling scams all the time.
That’s just wishful thinking, FINRA is far more likely to rubber stamp the application than to look critically at the recent trading of the legacy shares of the failed pharmaceutical company. They granted the name and ticker change rated quickly, so it should be pretty quick to get the RS out the door as well.
News 
Market Data 
Discover 
